Hematology TimesPonatinib back on the marketJanuary 19, 2014Leukemia, Myelodysplasia, TransplantationPharmacyALLCML
Hematology TimesOut-of-pocket costs hinder adherence to imatinibJanuary 8, 2014Leukemia, Myelodysplasia, TransplantationPharmacyCML
Hematology TimesNICE recommends pixantrone for NHLJanuary 7, 2014Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesFDA approves ibrutinib for previously treated MCLNovember 14, 2013Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesFraud, errors were behind delay of apixaban approval, report showsJuly 10, 2013ThrombosisPharmacy
Hematology TimesCompany suspends enrollment in drug trialsFebruary 21, 2013Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesEculizumab gets accelerated approval for aHUSSeptember 23, 2011AnemiaThrombosisPediatricsPharmacy
